There was no significant difference of CDC20 expression between bone marrow uninvolved MCL patients (n = 6) and healthy donors (n = 10), whereas CDC20 was overexpressed in MCL patients with bone marrow involvement (n = 11) (Fig. 1B). Here, CDC20 is linked to mantle cell lymphoma.